CN102552601B - Medicament for treating schizophrenia - Google Patents
Medicament for treating schizophrenia Download PDFInfo
- Publication number
- CN102552601B CN102552601B CN 201210064381 CN201210064381A CN102552601B CN 102552601 B CN102552601 B CN 102552601B CN 201210064381 CN201210064381 CN 201210064381 CN 201210064381 A CN201210064381 A CN 201210064381A CN 102552601 B CN102552601 B CN 102552601B
- Authority
- CN
- China
- Prior art keywords
- parts
- medicament
- schizophrenia
- treating
- treating schizophrenia
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
Abstract
The invention relates to a medicament for treating schizophrenia. The medicament is prepared form the following Chinese herbal medicines: fortune eupatorium herb, common club moss herb, orange peel, platycodon grandiflorum, perilla seed, hiptage benghalensis, almond and acorus gramineus. The medicament has a reasonable formula and exact curative effects and can be used for treating the schizophrenia effectively.
Description
Technical field
The present invention relates to field of medicaments, specifically, relate to the schizoid medicament of a kind of treatment.
Background technology
Schizophrenia (schizophrenia) is a kind of psychiatric department disease, it is a kind of lasting, common chronic great mental sickness, be the most serious a kind of in the psychosis, be with basic individual character, the division of thinking, emotion, behavior, the inharmonious of ergasia and environment is the modal psychosis of a class of principal character, many between twenty and fifty morbidities, and then influence behavior and emotion.The main sign of schizophrenia is considered to basic thinking structure and cognitive chipping.This phenomenon of dissociating it is believed that and can cause the thinking form disorders and cause differentiating inherent and external experience.Suffer from schizoid people and may oneself represent that hallucination is arranged, perhaps, other people can find that their performance is influenced by hallucination.The patient also may express obvious vain hope conviction.
At present, the demand for the schizoid medicine of treatment increases day by day.
Summary of the invention
The purpose of this invention is to provide the schizoid medicament of a kind of treatment.
In order to realize purpose of the present invention, the invention provides the schizoid medicament of a kind of treatment, it is to be made by weight by following bulk drugs:
1～10 part of 1～5 part of Radix Platycodonis of 1～5 part of Pericarpium Citri Reticulatae of 1～10 part of Herba Lycopodii of Herba Eupatorii
1～10 part of 1～10 part of Rhizoma Acori Graminei of 1～5 part of Semen Armeniacae Amarum of 1～10 part of Caulis Hiptages benghalensis of Folium Perillae.
Preferably, it is to be made by weight by following bulk drugs:
5 parts of 4 parts of Radix Platycodoniss of 3 parts of Pericarpium Citri Reticulataes of 5 parts of Herba Lycopodiis of Herba Eupatorii
10 parts of 5 parts of Rhizoma Acori Graminei of 5 parts of Semen Armeniacae Amarums of 6 parts of Caulis Hiptages benghalensis of Folium Perillae.
Medicament of the present invention can be made various dosage forms with pharmaceutically acceptable carrier, such as tablet, capsule, soft capsule, pill, granule, oral liquid or decoction etc.Can adopt preparation technique means well known in the art to finish medicaments preparation of the present invention.
Described pharmaceutically acceptable carrier is well known, for being used to prepare the usual excipients or the adjuvant of above-mentioned preparation.Excipient or adjuvant commonly used comprise (but being not limited to) filler, lubricant, dispersant, wetting agent, binding agent, antioxidant or the like, for example, syrup, arabic gum, sorbitol, lactose, dextrin, starch, calcium carbonate, Pulvis Talci, Polyethylene Glycol, carboxymethyl starch sodium, magnesium stearate or the like.
The reasonable recipe of medicament of the present invention, curative effect is clear and definite, can treat schizophrenia effectively.
The specific embodiment
Below the invention will be further described for the description by the specific embodiment, but this is not to be limitation of the present invention, those skilled in the art are according to basic thought of the present invention, can make various modifications or improvement, but only otherwise break away from basic thought of the present invention, all within the scope of the present invention.
The preparation of embodiment 1 capsule of the present invention
Take by weighing Herba Eupatorii 500 grams, Herba Lycopodii 300 grams, Pericarpium Citri Reticulatae 400 grams, Radix Platycodonis 500 grams, Folium Perillae 600 grams, Caulis Hiptages benghalensis 500 grams, Semen Armeniacae Amarum 500 grams, Rhizoma Acori Graminei 1000 grams.Be cut into coarse grain and add 12 times of amounts of water, 100 ℃ were heated 2 hours, filtered, and collected filtrate; Medicinal residues add 8 times of amounts of water, and 100 ℃ were heated 3 hours, filtered, and collected filtrate.Merge filtrate twice, filtrate decompression is concentrated into the thick paste of relative density about 1.25 (50 ℃), once finish spray drying, adorn 1000 capsules promptly.
Experimental example
Diagnostic criteria:
Draft according to " psychiatry " schizoid diagnostic criteria: verbal auditory ballucination appears in (1) repeatedly; (2) significantly loosening of association, splitting of thought, speech are discontinuous, or poverty of content of thought; (3) thought is inserted the people, is withdrawn, is sent out, thinking interrupts, or forced thinking; (4) passive, controlled, or known clearly experience; (5) vain hope of primary delusion (comprising delusional perception, delusional mood) or other absurdities; (6) thinking logic perversion, morbid symbolic thinking, or neologism; (7) parathymia, or significantly apathy; (8) tension syndrome, strange behavior, or unwise behavior; (9) tangible hypobulia or shortage.
Exclusion standard:
Get rid of organic mental disorders, and psychoactive drug substance and non-addiction material caused by mental disorder.The Split disease patient of not alleviating suffers from aforementioned two class diseases in this if break again as yet, should diagnose side by side.
Close case 60 examples of the standard of stating of selector, male's 30 examples wherein, 45 years old mean age, women's 30 examples, 51 years old mean age.
Therapeutic scheme
The capsule that makes among the oral embodiment 1, one day twice, each 3.Treating half a year continuously is a course of treatment.
Efficacy assessment standard
According to according to " psychiatry " (the Shen fishing. psychiatry is. Beijing: the People's Health Publisher, 2006:725-726) related standards, clinical efficacy drafted be produce effects: symptom fully or basic the disappearance, insight exists; Effectively: symptom disappears substantially, and the part insight exists; Invalid: symptom has no to alleviate, and insight does not recover.
Therapeutic outcome:
Through the treatment of a course of treatment, all the patient all meets the standard of produce effects.
Untoward reaction
After taking two groups of medicines, all do not find tangible untoward reaction.
Claims (1)
1. treat schizoid medicament for one kind, it is characterized in that it is to be made by weight by following bulk drugs:
5 parts of 4 parts of Radix Platycodoniss of 3 parts of Pericarpium Citri Reticulataes of 5 parts of Herba Lycopodiis of Herba Eupatorii
10 parts of 5 parts of Rhizoma Acori Graminei of 5 parts of Semen Armeniacae Amarums of 6 parts of Caulis Hiptages benghalensis of Folium Perillae.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210064381 CN102552601B (en) | 2012-03-13 | 2012-03-13 | Medicament for treating schizophrenia |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN 201210064381 CN102552601B (en) | 2012-03-13 | 2012-03-13 | Medicament for treating schizophrenia |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN102552601A CN102552601A (en) | 2012-07-11 |
| CN102552601B true CN102552601B (en) | 2013-07-24 |
Family
ID=46400055
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN 201210064381 Expired - Fee Related CN102552601B (en) | 2012-03-13 | 2012-03-13 | Medicament for treating schizophrenia |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN102552601B (en) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN103157092A (en) * | 2013-03-22 | 2013-06-19 | 徐道慧 | Drug for treating schizophrenia |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101253910A (en) * | 2008-03-23 | 2008-09-03 | 蓝子花 | Nuphar pumilum DC. grass root health tea |
-
2012
- 2012-03-13 CN CN 201210064381 patent/CN102552601B/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101253910A (en) * | 2008-03-23 | 2008-09-03 | 蓝子花 | Nuphar pumilum DC. grass root health tea |
Non-Patent Citations (5)
| Title |
|---|
| 万红娇，等.中医药治疗精神分裂症的临床研究概况.《江西中医学院学报》.2009,第21卷(第5期),第92-95页，参见全文. * |
| 甘记兴，等.夜合叶浓缩颗粒治疗慢性精神分裂症临床观察.《中国实用医药》.2008,第3卷(第34期),第162-163页，参见"1.2 方法". |
| 甘记兴,等.夜合叶浓缩颗粒治疗慢性精神分裂症临床观察.《中国实用医药》.2008,第3卷(第34期),第162-163页,参见"1.2 方法". * |
| 谭惠军，等.精神分裂症的中医辨证治疗.《国医论坛》.2006,第21卷(第6期),第35-36页，参见"痰气郁结型". |
| 谭惠军,等.精神分裂症的中医辨证治疗.《国医论坛》.2006,第21卷(第6期),第35-36页,参见"痰气郁结型". * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN102552601A (en) | 2012-07-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN102764340B (en) | Traditional Chinese medicine composite capable of improving sleep and preparation method and application thereof | |
| CN104666864A (en) | Traditional Chinese medicine for treating chronic pharyngitis | |
| CN105326803A (en) | Difenidol hydrochloride tablets for treating motion sickness and preparation method thereof | |
| CN101530579B (en) | A pharmaceutical composition for soothing the nerves | |
| CN102363022A (en) | Chinese medicine for treating postpartum anemic fainting | |
| CN102552601B (en) | Medicament for treating schizophrenia | |
| CN104223073B (en) | A kind of food, health products or pharmaceutical composition of sleeping | |
| CN103948742B (en) | Pharmaceutical composition for improving male animal sexual dysfunction | |
| CN102657828A (en) | Pharmaceutical composition for treating chronic heart failure | |
| CN104547633A (en) | Traditional Chinese medicine composition for treating cervical vertebra disease and preparation method thereof | |
| CN105663405A (en) | Medicine for treating habitual abortion | |
| CN104257795A (en) | Medicine for treating cold | |
| CN102973877A (en) | Pharmaceutical composition for treating depression | |
| CN103301324A (en) | Traditional Chinese medicine for treating nerve headache | |
| CN102008623A (en) | Traditional Chinese medicine preparation for treating Meniere's syndrome | |
| CN102657775B (en) | Medicament composition for treating depression | |
| CN102670800B (en) | Traditional Chinese medicine for treating cold | |
| CN102813899A (en) | Medicament for treating intractable vertigo | |
| CN101579481B (en) | Medicinal composition for treating hypertension | |
| CN103157092A (en) | Drug for treating schizophrenia | |
| CN102552456B (en) | Medicament for treating anxiety neurosis | |
| CN102743450B (en) | Traditional Chinese medicine composition for preventing early no-fetal-heart pregnancy and application | |
| CN103372168A (en) | Chinese medicinal composition for treating night sweating | |
| CN103495014A (en) | Medicament for treating depression in psychiatric nursing | |
| CN103417892A (en) | Children's bedwetting treatment medicine |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| C14 | Grant of patent or utility model | ||
| GR01 | Patent grant | ||
| ASS | Succession or assignment of patent right |
Owner name: JIANGSU NEWHOPE RENEWABLE ENERGY S+T CO., LTD. Free format text: FORMER OWNER: LI XIUYING Effective date: 20131129 |
|
| C41 | Transfer of patent application or patent right or utility model | ||
| COR | Change of bibliographic data |
Free format text: CORRECT: ADDRESS; FROM: 272051 JINING, SHANDONG PROVINCE TO: 213399 CHANGZHOU, JIANGSU PROVINCE |
|
| TR01 | Transfer of patent right |
Effective date of registration: 20131129 Address after: 213399 Jiangsu city of Changzhou province Liyang Liyang Town of Wuhu Shanghai Road No. 168 Patentee after: Jiangsu Newhope Renewable Energy Science & Technology Co., Ltd. Address before: 272051 Shandong province Jining City Ji wearing No. 1 Shandong Road, Jining province mental disease hospital Patentee before: Li Xiuying |
|
| CF01 | Termination of patent right due to non-payment of annual fee |
Granted publication date: 20130724 Termination date: 20150313 |
|
| EXPY | Termination of patent right or utility model |